Study details
Enrolling now
Long-Term COVID and Rehabilitation Trial
VA Office of Research and Development
NCT IDNCT05373043ClinicalTrials.gov data as of Apr 2026
Target enrollment
300
Study length
about 6 years
Ages
50+
Locations
1 site in UT
What this study is about
Researchers are testing whether Mitoquinone, a dietary supplement, helps improve vascular endothelial function in adults recovering from long-COVID. The trial will last for 2191 days and involve approximately 300 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Mitoquinone
- 2.Placebo
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.